Research keywords (1)：
Clinical Psychopharmacology
Research theme for competitive and other funds (1)：
2020 - 2023 抗精神病薬持効性薬への切替が受診状況及び併用向精神薬投与に与える影響の検討
Papers (19)：
Hiroyoshi Takeuchi, Yoshiteru Takekita, Hikaru Hori, Kazuto Oya, Itaru Miura, Naoki Hashimoto, Norio Yasui-Furukori. Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms. Hum Psychopharmacol . 2021
Taro Kishi, Ikuo Nomura, Kenji Sakuma, Makoto Okuya, Kazuto Oya, Nakao Iwata. The Efficacy and Safety of Lacosamide for Bipolar Depression: A 12-Week Open-Label Pilot Trial. J Clin Psychopharmacol . 2021. 41. 2. 204-206
岸太郎, 江角悟, 大矢一登, 奥谷理, 佐久間健二, 野村郁雄, 橋本保彦, 波多野正和, 波多野正和, 松井佑樹, et al. Efficacy and safety of lithium and lamotrigine for the bipolar disorder in the maintenance phase: A systematic review and meta-analysis. 臨床精神薬理. 2021. 24. 9
大矢 一登, 岸 太郎, 岩田 仲生. エビリファイ持続性水懸筋注用の効果と忍容性に関する系統的レビューとメタ解析(Efficacy and Tolerability of Aripiprazole Once-monthly for Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials). 日本神経精神薬理学会年会プログラム・抄録集. 2016. 46回. 211-211
Efficacy and Tolerability of Aripiprazole Once-monthly for Schizophrenia : A Systematic Review and Meta-Analysis of Randomized Controlled Trials
(JSNP2016 2016)
Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
(2014)
Efficacy and Tolerability of Histamine-2 Receptor Antagonist Adjunction of Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
(2014)
悪性症候群と診断された26例の検討
(第173回東海精神神経学会 2014)
Professional career (1)：
M.D. Ph.D. (藤田医科大学)
Awards (1)：
2020/08 - NPPR NPPR Topic Award 2020 Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design
